MEROPENEM/VABORBACTAM
Approved January 2021 with restriction to Infectious Disease for high-risk patients with known MDRO infection that has failed treatment with other gram-negative antibiotics.
Approved January 2021 with restriction to Infectious Disease for high-risk patients with known MDRO infection that has failed treatment with other gram-negative antibiotics.